During the past decade, CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard" are "Alzheimer's Disease" (1 trials) and "Alzheimer´s Disease" (1 trials). Many other conditions were trialed in "CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard" in a lesser frequency.

Most popular intervention types in "CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "AFFITOPE® AD02" (1 trials), "Placebo" (1 trials), "active: AFFITOPE AD02" (1 trials) and "control: Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard" are 2 trials for "All" genders.

Currently, there are NaN active trials in "CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CMRR Hôpital Pellegrin, Bâtiment USN Tastet Girard, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".